Michael Gibbons

1972–2025 年に発表

51
論文数
19,869
被引用数
37
h 指数
47
i10 指数

被引用数

Michael Gibbons の年別被引用数1974 年: 被引用 1 件1975 年: 被引用 1 件1977 年: 被引用 1 件1979 年: 被引用 2 件1980 年: 被引用 2 件1984 年: 被引用 4 件1987 年: 被引用 1 件1988 年: 被引用 1 件1990 年: 被引用 1 件1991 年: 被引用 2 件1992 年: 被引用 2 件1993 年: 被引用 3 件1994 年: 被引用 3 件1995 年: 被引用 6 件1996 年: 被引用 9 件1997 年: 被引用 12 件1998 年: 被引用 11 件1999 年: 被引用 22 件2000 年: 被引用 24 件2001 年: 被引用 27 件2002 年: 被引用 20 件2003 年: 被引用 63 件2004 年: 被引用 53 件2005 年: 被引用 78 件2006 年: 被引用 75 件2007 年: 被引用 96 件2008 年: 被引用 81 件2009 年: 被引用 94 件2010 年: 被引用 91 件2011 年: 被引用 110 件2012 年: 被引用 114 件2013 年: 被引用 126 件2014 年: 被引用 150 件2015 年: 被引用 117 件2016 年: 被引用 124 件2017 年: 被引用 115 件2018 年: 被引用 96 件2019 年: 被引用 199 件2020 年: 被引用 198 件2021 年: 被引用 277 件2022 年: 被引用 267 件2023 年: 被引用 245 件2024 年: 被引用 369 件2025 年: 被引用 168 件2026 年: 被引用 5 件1976 年は被引用が無いため表示していません1978 年は被引用が無いため表示していません1981〜1983 年は被引用が無いため表示していません1985〜1986 年は被引用が無いため表示していません1989 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 981 件、この内訳の 20%イギリス: 引用元論文 679 件、この内訳の 13.8%中国: 引用元論文 323 件、この内訳の 6.6%ドイツ: 引用元論文 270 件、この内訳の 5.5%オランダ: 引用元論文 245 件、この内訳の 5%カナダ: 引用元論文 206 件、この内訳の 4.2%オーストラリア: 引用元論文 178 件、この内訳の 3.6%イタリア: 引用元論文 172 件、この内訳の 3.5%フランス: 引用元論文 162 件、この内訳の 3.3%スペイン: 引用元論文 132 件、この内訳の 2.7%スウェーデン: 引用元論文 127 件、この内訳の 2.6%日本: 引用元論文 116 件、この内訳の 2.3%
0%20%その他 26.9%

分野

  • Medicine37.6%
  • Social Sciences11%
  • Business, Management and Accounting8.6%
  • Decision Sciences8.2%
  • Health Professions7.4%
  • Computer Science6.3%
  • その他20.9%

トピック

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis6.4%
  • Innovation and Knowledge Management2.2%
  • Long-Term Effects of COVID-192%
  • University-Industry-Government Innovation Models1.9%
  • scientometrics and bibliometrics research1.9%
  • Systemic Sclerosis and Related Diseases1.8%
  • その他83.8%

共著者

全論文

検索で開く
  1. Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Arvind Rajasekaran, Lisa Spencer, Vicky Tsipouri, Zhe Wu, Georgio Xydopoulos, Fernando Zanghelini - The Lancet Respiratory Medicine 2022 被引用: 271

  2. Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Coimbatore Sree Vidya, Rebecca R. Baron, Timothy Clouser, Tracy J. Doyle, Anthony H. Maeda, Kristin B. Highland, Jemima F. Albayda, Sarah E. Collins, Karthik Suresh, John M. Davis, Andrew H. Limper, Isabel Amigues, Kristina Eliopoulos, Jeffery J. Swigris, Stephen M. Humphries, John Huntwork, Chris Glynn, Steve Duncan, Maria I. Danila, Marilyn K. Glassberg, Elana M. Oberstein, Elizabeth A. Belloli, Linda Briggs, Vivek Nagaraja, Linda Cholewa, Donna DiFranco, Edward Green, Christie Liffick, Tanvi Naik, Genevieve Montas, Dorota Lebiedz‐Odrobina, Reba Bissell, Mark H. Wener, Lisa Lancaster, Leslie J. Crawford, Karmela K Chan, Robert J. Kaner, Alicia Morris, Xiaoping Wu, Nader Khalidi, Christopher J. Ryerson, Alyson W. Wong, Charlene D. Fell, Sharon LeClercq, Mark Hyman, Shane Shapera, Shikha Mittoo, Shireen Shaffu, Karl Gaffney, Andrew M. Wilson, Shaney Barratt, Harsha Gunawardena, Rachel K. Hoyles, Joel David, Namrata Kewalramani, Toby M. Maher, Philip L. Molyneaux, Maria Kokosi, Matthew Cates, Mandizha Mandizha, Abdul Ashish, Gladstone Chelliah, Helen Parfrey, Muhunthan Thillai, Josephine Vila, Sophie Fletcher, Paul Beirne, C Favager, Jo Brown, Julie Dawson ほか 7 名 - The Lancet Respiratory Medicine 2022 被引用: 208

  3. Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2020 被引用: 219

  4. Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tamera J. Corte, Ian Glaspole, Nicole Goh, Mark Holmes, M.A. Malouf, Francis Thien, Elizabeth Veitch, Benjamin Bondue, Caroline Dahlqvist, Antoine Froidure, Hans Slabbynck, Wim Wuyts, Claudia Cartagena Salinas, Rosa Feijoó Seoane, Victor D. Martínez, Roxana Maturana, Juana Pavie Gallegos, Andrés Rosenblüt, Rafael Silva, Alvaro Undurraga Pereira, Martina Doubková, Norbert Pauk, Martina Plačková, Martina Šterclová, Elisabeth Bendstrup, Saher Burhan Shaker, Ingrid Louise Titlestad, Stephan Budweiser, Christian Grohé, Dirk Koschel, Michael Kreuter, Antje Prasse, Michael Weber, Hubert Wirtz, Κατερίνα Αντωνίου, Zoe Daniil, Mina Gaga, Despoina Papakosta, Shinyu Izumi, Masaki Okamoto, Alfredo Guerreros Benavides, Carlos Barrera, Alejandro Manuel Peña Villalobos, Aranzazu Campo Ezquibela, José M. Cifrián, Estrella Fernández Fabrellas, Virginia Leiro, María Molina‐Molina, Asunción Nieto Barbero, Jacobo Sellarés, Claudia Valenzuela, Shih-Lung Cheng, Ping‐Hung Kuo, Kang‐Yun Lee, Chau‐Chyun Sheu, Hakan Günen, Nesrin Moğulkoç, Sibel Naycı, Huzaifa Adamali, Stephen Bianchi, Nazia Chaudhuri, Michael Gibbons, Simon P. Hart, Philip L. Molyneaux, Helen Parfrey, Gauri Saini, Lisa Spencer, Sarah Wiscombe, Danielle Antin‐Ozerkis, Rebecca Bascom ほか 152 名 - JAMA 2023 被引用: 127

  5. Ly6Chi Monocytes Direct Alternatively Activated Profibrotic Macrophage Regulation of Lung Fibrosis

    著者: , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2011 被引用: 473

  6. Regulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3

    著者: , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2011 被引用: 521

  7. Telomere length and risk of idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease: a mendelian randomisation study

    著者: , , , , , , , , , , - The Lancet Respiratory Medicine 2020 被引用: 231

  8. Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post–COVID-19 Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ewen M. Harrison, Melissa Heightman, Toby Hillman, Alex Horsley, Linzy Houchen‐Wolloff, Ian Jarrold, Simon R. Johnson, Mark G. Jones, Fasihul Khan, Rod Lawson, Olivia C. Leavy, Nazir Lone, Michael Marks, Hamish McAuley, Puja Mehta, Dhruv Parekh, Karen Piper Hanley, Manuela Platé, John E. Pearl, Krisnah Poinasamy, Jennifer K Quint, Betty Raman, Matthew Richardson, Pilar Rivera‐Ortega, Laura Saunders, Ruth Saunders, Malcolm G. Semple, Marco Sereno, Aarti Shikotra, A. John Simpson, Amisha Singapuri, D Smith, Mark Spears, Lisa Spencer, Stefan Stanel, David Thickett, A. A. Roger Thompson, Mathew Thorpe, Simon Walsh, S Walker, Nicholas Weatherley, Mark C. Willingham, Jim M. Wild, Dan Wootton, Christopher E. Brightling, Ling‐Pei Ho, Louise V. Wain, Gísli Jenkins - American Journal of Respiratory and Critical Care Medicine 2022 被引用: 150

  9. The New Production of Knowledge: The Dynamics of Science and Research in Contemporary Societies.

    著者: , , , , , , - Contemporary Sociology A Journal of Reviews 1995 被引用: 4,459

  10. Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark Anderson, Gareth Davies, William Dickey, A Murdock, G. A. Turner, Andrew Goddard, Stephen Gore, Chris Haigh, Timothy Harding, L. Jackson, Iain Murray, Joy Worthingon, Thomas Lee, Peik Loon Lim, James McLoughlin, Christopher Macdonald, Philip Mairs, David Gabriel Monk, Sean Preston, Stirling Pugh, Howard Smart, Ashraf Soliman, Peter Isaacs, David Aldulaimi, Nigel Trudgill, Julian Teare, A. Ben-Hamida, Andrew Bell, Robert Boulton-Jones, Tawfique K. Daneshmend, Hisaharu Suzuki, Sue Cullen, Rebecca C. Fitzgerald, Rupert Ransford, Mohammad Mesbahur Rahman, Giovanni Domenico Tebala, M. Hallissey, Carrie Kelly, Tamas Hickish, Ali S. Taha, J. W. Rademaker, M. Whitehead, Sean G. Kelly, Perminder Phull, Naveen Sharma, Ian Perry, Vankatraman Sankara-Raman, Haythem Ali, Iqbal Ansary Khan, Howard Curtis, Martin Wadley, Adam Stone, Sumesh Sukumaran, Andrew Higham, Stephen F. Lewis, Adam Haycock, Bernhard Usselmann, Simon D. Johnston, Tony Tham, S. Campbell, Andrew Douds, Jason Dunn, Ian Sargeant, Mark Narain, Nick Maynard, Andrew Chilton, Susi Green, Duncan E. Loft, Bart Decadt, Michael A. Mendall ほか 2 名 - The Lancet 2018 被引用: 265

  11. The burden of progressive fibrotic interstitial lung disease across the UK

    著者: , , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2021 被引用: 72

  12. Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Minna Purokivi, Terhi Rantala, Vincent Cottin, Françis Couturaud, Dominique Israël‐Biet, S. Jouneau, Romain Kessler, François Lebargy, S. Marchand‐Adam, Tom Bollmann, Andreas Günther, Peter Hammerl, J Kirschner, Anne‐Marie Kirsten, Michael Kreuter, Claus Neurohr, Antje Prasse, Nicolas Schönfeld, Rainer Wiewrodt, Attila Somfay, Balazs Medgyasszay, Eszter Csánky, György Losonczy, Hiroki Hayashi, Sakae Homma, Yoshikazu Inoue, Shinyu Izumi, Hideya Kitamura, Yasuhiko Nishioka, Osamu Nishiyama, Takashi Ogura, Masaki Okamoto, Takefumi Saito, Hiroyuki Taniguchi, Yoshiaki Zaizen, Marzena Filipowska, Agnieszka Jarzemska, Władysław Pierzchała, Wojciech Piotrowski, Krzysztof Sładek, Ewa Trawińska, Young Whan Kim, Jong Sun Park, Jin Woo Song, Myriam Aburto, Diego Castillo Villegas, José María Echave-Sustaeta, Christian García Fadul, Susana Herrera, Jorge Moisés, María Molina‐Molina, Amália Moreno, Asunción Nieto, María Jesús Rodríguez‐Nieto, José Antonio Rodríguez-Portal, Belén Safont, Jacobo Sellarés, Claudia Valenzuela, Huzaifa Adamali, Nazia Chaudhuri, Michael Gibbons, Rachel K. Hoyles, Toby M. Maher, Helen Parfrey, Francis Averill, Steven Chambers, Neil Ettinger, G. Giessel, Lisa Jones, Mitchell Kaye ほか 3 名 - The Lancet Respiratory Medicine 2019 被引用: 104

  13. Respiratory follow-up of patients with COVID-19 pneumonia

    著者: , , , , , , , , , , , , - Thorax 2020 被引用: 398

  14. Introduction: `Mode 2' Revisited: The New Production of Knowledge

    著者: , , - Minerva 2003 被引用: 1,208

  15. Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John Hutchinson, Killian Hurley, Mark G. Jones, Steve Jones, Maria Kokosi, Michael Kreuter, Laura Mackay, Siva Mahendran, George Margaritopoulos, María Molina‐Molina, Philip L. Molyneaux, Aiden O’Brien, Katherine Ma O’Reilly, Alice Packham, Helen Parfrey, Venerino Poletti, Joanna C. Porter, Elisabetta Renzoni, Pilar Rivera‐Ortega, Anne‐Marie Russell, Gauri Saini, Lisa Spencer, Giulia Maria Stella, Helen Stone, Sharon Sturney, David Thickett, Muhunthan Thillai, T Wallis, Katie Ward, Athol U. Wells, Alex West, Melissa Wickremasinghe, Felix Woodhead, Glenn Hearson, Lucy Howard, J. Kenneth Baillie, Peter Openshaw, Malcolm G. Semple, Iain Stewart, Gísli Jenkins - American Journal of Respiratory and Critical Care Medicine 2020 被引用: 239

  16. Nintedanib for non-IPF progressive pulmonary fibrosis: 12-month outcome data from a real-world multicentre observational study

    著者: , , , , , , , , , , , , , , , , , , , , , , - ERJ Open Research 2022 被引用: 33

  17. Mode 2 society and the emergence of context-sensitive science

    著者: - Science and Public Policy 2000 被引用: 357

  18. The New Production of Knowledge: The Dynamics of Science and Research in Contemporary Societies

    著者: , , , , , - 2010 被引用: 283

  19. Re-Thinking Science: Knowledge and the Public in an Age of Uncertainty

    著者: , , , , - Contemporary Sociology A Journal of Reviews 2003 被引用: 3,415

  20. Multi-center evaluation of baseline neutrophil-to-lymphocyte (NLR) ratio as an independent predictor of mortality and clinical risk stratifier in idiopathic pulmonary fibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - EClinicalMedicine 2022 被引用: 30

  21. Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew M. Wilson, Elizabeth Butcher, Sy Giin Chong, Gauri Saini, Sabrina Zulfikar, Felix Chua, Peter M. George, Maria Kokosi, Vasileios Kouranos, Philip L. Molyneaux, Elisabetta Renzoni, B Vitri, Athol U. Wells, Lisa Nicol, Stephen Bianchi, Raman Kular, Huajian Liu, Alexander John, Sarah Barth, Melissa Wickremasinghe, Ian Forrest, Ian Grimes, A. John Simpson, Sophie Fletcher, Mark G. Jones, Emma Kinsella, Jennifer Naftel, Nicola Wood, Jodie Chalmers, Anjali Crawshaw, Louise Crowley, Davinder Dosanjh, Christopher Huntley, Gareth Walters, Timothy Gatheral, Catherine Plum, Shiva Bikmalla, Raja Muthusami, Helen Stone, Jonathan Rodrigues, Krasimira Tsaneva‐Atanasova, Chris J. Scotton, Michael Gibbons, Shaney Barratt - ERJ Open Research 2024 被引用: 24

  22. The New Production of Knowledge

    著者: - Medical Entomology and Zoology 1994 被引用: 3,224

  23. Science's new social contract with society

    著者: - Nature 1999 被引用: 885

  24. A Historical Overview of Health Disparities and the Potential of eHealth Solutions

    著者: - Journal of Medical Internet Research 2005 被引用: 141